
The Aesthetics Journal | November 2025
https://issuu.com/aestheticsjournal/docs/november_2025_skin_rejuvenation_topicals

https://issuu.com/aestheticsjournal/docs/november_2025_skin_rejuvenation_topicals

Consultant dermatologist Dr Clare Kiely explores the mechanisms of photodamage and effective topical treatments With an ageing population, caring for our skin health has never been so important. Photoageing is

Discover the latest gift set collections for this year’s festive season. iS Clinical launches two additional festive sets Skincare company iS Clinical has unveiled the Smoothing Essentials collection alongside the

Aesthetic manufacturer Teoxane has introduced Joanna Underhill as new general manager for the UK&I. Teoxane shares that Underhill joins the company from pharmaceutical company Allergan Aesthetics, an AbbVie company, where

Medical aesthetics company Laboratoires FILLMED has launched the FILLMED SKIN PERFUSION ARCHITECH PRO CREAM as part of its SKIN PERFUSION collection. The company shares that the cream is formulated with

Consultant dermatologist Dr Clare Kiely explores the mechanisms of photodamage and effective topical treatments With an ageing population, caring for our skin health has never been so important. Photoageing is

The Commission on Human Medicines (CHM) has endorsed changes to the prescribingguidance of isotretinoin. This comes after the Isotretinoin Expert Working Group (IEWG) and CHM published a report in 2023

Aesthetic device company Lynton Lasers has launched its distribution of the RedTouch PRO, following its initial unveiling at the Clinical Cosmetic Regenerative Congress (CCR) 2025. Developed by manufacturing company DEKA,

Skincare company Revision Skincare has introduced the Tinted YouthFull Lip Replenisher. Available though aesthetic distributor AestheticSource, the product aims to target visible signs of ageing on the lips, whilst defending

Aesthetic nurse prescriber Anna Baker discusses multi-modality approaches to addressing tissue changes with glucagon-like peptide-1 agonists and glucose-dependent insulinotropic polypeptide therapies Current literature suggests that medical aesthetic practitioners are noticing